Literature DB >> 14708107

Independent de novo 22q11.2 deletions in first cousins with DiGeorge/velocardiofacial syndrome.

Sulagna C Saitta1, Stacy E Harris, Donna M McDonald-McGinn, Beverly S Emanuel, Melissa K Tonnesen, Elaine H Zackai, Suzanne C Seitz, Deborah A Driscoll.   

Abstract

Deletions of chromosome 22q11.2 are found in the vast majority of patients with DiGeorge/velocardiofacial syndrome (DGS/VCFS). This most frequent microdeletion syndrome is estimated to occur in 1 in 4,000 live births. The majority of deletions are de novo, with 10% or less inherited from an affected parent. Here, we report two separate families with recurrence of a 22q11.2 deletion in first cousins. In each family, unaffected siblings (brother and sister) had an affected child. Fluorescence in situ hybridization (FISH) studies of the parents of each affected child were normal and hence, relatives were not considered at an increased risk for recurrence in another pregnancy. We used highly polymorphic microsatellite repeat markers from within 22q11.2 to determine the parental origin of each cousin's deletion and to assess whether parental germline mosaicism for the 22q11.2 deletion might be a factor in these cases. This analysis confirmed that in each case, the deletion occurred on a chromosome 22 derived from unrelated parents, consistent with independent de novo deletion events. Thus, we concluded that germline mosaicism as the underlying mechanism for affected cousins in these families was unlikely. Our findings underscore the high frequency with which the 22q11.2 deletion occurs in the general population and demonstrate the important role that PCR-based parental origin determination can have in recurrence risk counselling. Furthermore, relatives of affected individuals may benefit from genetic counselling and consider prenatal testing for the 22q11.2 deletion in future pregnancies, despite a low recurrence risk. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 14708107      PMCID: PMC2811370          DOI: 10.1002/ajmg.a.20421

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  13 in total

Review 1.  Segmental duplications: an 'expanding' role in genomic instability and disease.

Authors:  B S Emanuel; T H Shaikh
Journal:  Nat Rev Genet       Date:  2001-10       Impact factor: 53.242

2.  A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11.

Authors:  D A Driscoll; M L Budarf; B S Emanuel
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

Review 3.  Developmental genetics of the heart.

Authors:  J Burn; J Goodship
Journal:  Curr Opin Genet Dev       Date:  1996-06       Impact factor: 5.578

4.  Deletion of 22q11 in two brothers with different phenotype.

Authors:  L Kasprzak; V M Der Kaloustian; A M Elliott; M Shevell; C Lejtenyi; P Eydoux
Journal:  Am J Med Genet       Date:  1998-01-23

Review 5.  The 22q11.2 deletion syndrome.

Authors:  B S Emanuel; D McDonald-McGinn; S C Saitta; E H Zackai
Journal:  Adv Pediatr       Date:  2001

6.  The 22q11.2 deletion: screening, diagnostic workup, and outcome of results; report on 181 patients.

Authors:  D M McDonald-McGinn; D LaRossa; E Goldmuntz; K Sullivan; P Eicher; M Gerdes; E Moss; P Wang; C Solot; P Schultz; D Lynch; P Bingham; G Keenan; S Weinzimer; J E Ming; D Driscoll; B J Clark; R Markowitz; A Cohen; T Moshang; P Pasquariello; P Randall; B S Emanuel; E H Zackai
Journal:  Genet Test       Date:  1997

7.  PCR assay for screening patients at risk for 22q11.2 deletion.

Authors:  D A Driscoll; B S Emanuel; L E Mitchell; M L Budarf
Journal:  Genet Test       Date:  1997

8.  Recurrent 22q11.2 deletion in a sibship suggestive of parental germline mosaicism in velocardiofacial syndrome.

Authors:  P Sandrin-Garcia; C Macedo; L R Martelli; E S Ramos; M L Guion-Almeida; A Richieri-Costa; G A S Passos
Journal:  Clin Genet       Date:  2002-05       Impact factor: 4.438

9.  Molecular confirmation of germ line mosaicism for a submicroscopic deletion of chromosome 22q11.

Authors:  E Hatchwell; F Long; J Wilde; J Crolla; K Temple
Journal:  Am J Med Genet       Date:  1998-06-30

10.  Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net!

Authors:  D M McDonald-McGinn; M K Tonnesen; A Laufer-Cahana; B Finucane; D A Driscoll; B S Emanuel; E H Zackai
Journal:  Genet Med       Date:  2001 Jan-Feb       Impact factor: 8.822

View more
  5 in total

1.  A case of 3q29 microdeletion syndrome involving oral cleft inherited from a nonaffected mosaic parent: molecular analysis and ethical implications.

Authors:  Aline L Petrin; Sandra Daack-Hirsch; Jamie L'Heureux; Jeffrey C Murray
Journal:  Cleft Palate Craniofac J       Date:  2010-05-04

2.  Scribble Controls Social Motivation Behavior through the Regulation of the ERK/Mnk1 Pathway.

Authors:  Maïté M Moreau; Susanna Pietropaolo; Jérôme Ezan; Benjamin J A Robert; Sylvain Miraux; Marlène Maître; Yoon Cho; Wim E Crusio; Mireille Montcouquiol; Nathalie Sans
Journal:  Cells       Date:  2022-05-10       Impact factor: 7.666

3.  Aberrant interchromosomal exchanges are the predominant cause of the 22q11.2 deletion.

Authors:  Sulagna C Saitta; Stacy E Harris; Ann P Gaeth; Deborah A Driscoll; Donna M McDonald-McGinn; Melissa K Maisenbacher; Jill M Yersak; Prabir K Chakraborty; April M Hacker; Elaine H Zackai; Terry Ashley; Beverly S Emanuel
Journal:  Hum Mol Genet       Date:  2003-12-17       Impact factor: 6.150

4.  Prenatal sonographic and cytogenetic/molecular findings of 22q11.2 microdeletion syndrome in 48 confirmed cases in a single tertiary center.

Authors:  Tugba Sarac Sivrikoz; Seher Basaran; Recep Has; Birsen Karaman; Ibrahim Halil Kalelioglu; Melike Kirgiz; Umut Altunoglu; Atil Yuksel
Journal:  Arch Gynecol Obstet       Date:  2021-06-18       Impact factor: 2.344

5.  Sex-specific recombination patterns predict parent of origin for recurrent genomic disorders.

Authors:  Trenell J Mosley; H Richard Johnston; David J Cutler; Michael E Zwick; Jennifer G Mulle
Journal:  BMC Med Genomics       Date:  2021-06-09       Impact factor: 3.063

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.